5 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Lung Neoplasm: new trials by email Literature Review of Lung Neoplasm trials Research Report on Lung Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. COM701, COM701 with Opdivo (Nivolumab). - Advanced Cancer, Ovarian Cancer | Phase 1 | Completed | Compugen Ltd | 121 | 2018-09-06 | 2025-01-17 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors pralsetinib (BLU-667) - RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer | Phase 1 / Phase 2 | Completed | Hoffmann-La Roche | 590 | 2017-03-17 | 2025-05-31 |
| Hypofractionated Radiotherapy for Small Cell Lung Cancer hypofractionated external beam - Lung Neoplasm, Small Cell Carcinoma | Phase 1 | Completed | AHS Cancer Control Alberta | 24 | 2007-03-01 | 2016-02-25 |
| An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer EP2101 - Carcinoma, Non-Small-Cell Lung, Lung Neoplasm | Phase 1 | Completed | Epimmune | 18 | 2003-01-01 | 2010-03-24 |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 TAK-165 - Breast Neoplasm, Pancreatic Neoplasm | Phase 1 | Completed | Takeda | 16 | 2002-06-01 | 2012-02-02 |
Lung Neoplasms (5) · Neoplasms (4) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Ovarian Neoplasms (2) · Adenocarcinoma (1) · Adenocarcinoma, Papillary (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Large Cell (1) · Carcinoma, Medullary (1) · Carcinoma, Neuroendocrine (1)
Lung Diseases (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4) · Adnexal Diseases (2) · Breast Diseases (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2)
Nivolumab (1) · TAK-165 (1) · pralsetinib (1)
AHS Cancer Control Alberta (1) · Compugen Ltd (1) · Epimmune (1) · Hoffmann-La Roche (1) · Takeda (1)
United States (4) · Belgium (1) · Canada (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Don Yee, MD (1)
PMID 34118197, PMID 34118198, PMID 35715405, PMID 35962206, PMID 37282666, PMID 37916501, PMID 37934000, PMID 38009200, PMID 40639400, PMID 41886723
2016 (1)